Waverley Pharma (WAVE) Price & Analysis
WAVE Stock Chart & Stats
CA$0.01CA$0.00(0.00%)
At close: 4:00 PM EDT
- Day’s Range
- CAD 0.01 - CAD 0.01
- 52-Week Range
- CAD 0.01 - CAD 0.04
- Previous Close
- CAD 0.01
- Volume
- 7,500
- Average Volume (3M)
- 333
- Market Cap
- CAD 540.00K
- Enterprise Value
- CAD 4.91M
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- CAD 40.00K
- Price to Earnings (P/E)
- ―
- Beta
- 0.91
- Next Earnings
- Nov 20, 2026
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Waverley Pharma News
WAVE FAQ
What was Waverley Pharma’s price range in the past 12 months?
Waverley Pharma lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Waverley Pharma’s market cap?
Waverley Pharma’s market cap is C$540.00K.
When is Waverley Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Waverley Pharma’s earnings last quarter?
Waverley Pharma released its earnings results on Aug 27, 2026. The company reported -C$0.003 earnings per share for the quarter.
Is Waverley Pharma overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Waverley Pharma pay dividends?
Waverley Pharma does not currently pay dividends.
What is Waverley Pharma’s EPS estimate?
Waverley Pharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Waverley Pharma have?
Waverley Pharma has 54,000,000 shares outstanding.
What happened to Waverley Pharma’s price movement after its last earnings report?
Waverley Pharma reported an EPS of -C$0.003 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Waverley Pharma?
Currently, no hedge funds are holding shares in TSE:WAVE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Waverley Pharma
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
- Sector
- General
- Industry
- Medical - Pharmaceuticals
- CEO
- Larry Thiessen
- Employees
- 0
- Website
- www.waverleypharma.com
- Address
- 4-1250 Waverley Street, Winnipeg, MB, R3T 6C6, CA
Waverley Pharma (WAVE) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 1 | 13 |
| Technical Analysis | 3 | 1 | 3 |
| Moving Averages | 2 | 0 | 10 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| TSE:WESA.XWesana Health Holdings Inc | ||
| TSE:BETRBetterLife Pharma |